Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 History  





2 Legal status  





3 See also  





4 References  














MON 863: Difference between revisions






Dansk
Français
 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 





Help
 

From Wikipedia, the free encyclopedia
 


Browse history interactively
 Previous edit
Content deleted Content added
Citation bot (talk | contribs)
4,992,198 edits
Alter: title. Removed parameters. | Use this bot. Report bugs. | Suggested by Whoop whoop pull up | #UCB_webform 178/193
 
(23 intermediate revisions by 17 users not shown)
Line 1: Line 1:

{{Short description|Variety of maize}}

'''MON 863''' is a [[genetic engineering|genetically engineered]] variety of [[maize]] produced by [[Monsanto]].

'''MON 863''' is a [[Genetically modified maize|genetically engineered variety of maize]] produced by [[Monsanto]]. It is genetically altered to express a modified version of [[Cry3Bb1]], a delta endotoxin which originates from ''[[Bacillus thuringiensis]]''.<ref name='Greenpeace MON863 chronicle'>{{cite web | url = http://www.greenpeace.org/international/Global/international/planet-2/report/2007/3/mon863_chronicle_of_deception.pdf | title = The MON863 case - a chronicle of systematic deception | access-date = 2010-07-22 | publisher = [[Greenpeace]] | quote = MON863 is a genetically modified corn that expresses a Bt-toxin. This toxin is a modified version of the delta endotoxin Cry3Bb1 which originates from the microorganism Bacillus thuringiensis. The genetic manipulation is aimed at protecting maize plants against a pest called corn rootworm (Diabrotica spp.). MON863 differs from other Bt-corns already placed on the market (MON810, BT11, Bt176), which produce a modified Cry1Ab toxin conferring resistance to a pest called European corn borer (Ostrinia nubilalis), in that it produces an artificial Cry3Bb1 toxin. In addition to the modified Cry3Bb1 toxin gene MON863 contains an antibiotic resistance marker gene.}}</ref><ref name='Doull 2007 genetics'>{{cite journal |doi=10.1016/j.fct.2007.08.033 |title=Report of an Expert Panel on the reanalysis by of a 90-day study conducted by Monsanto in support of the safety of a genetically modified corn variety (MON 863) |year=2007 |last1=Doull |first1=J. |last2=Gaylor |first2=D. |last3=Greim |first3=H.A. |last4=Lovell |first4=D.P. |last5=Lynch |first5=B. |last6=Munro |first6=I.C. |journal=[[Food and Chemical Toxicology]] |volume=45 |issue=11 |pages=2073–85 |pmid=17900781}}</ref> This protects the plant from [[Diabrotica|corn rootworm]].<ref name='Doull 2007 genetics' /><ref name='Coghlan 2010-01-22'>{{cite news | first = Andy | last = Coghlan | title = Engineered maize toxicity claims roundly rebuffed | date = 2010-01-22 | url = https://www.newscientist.com/article/mg20527444.000-engineered-maize-toxicity-claims-roundly-rebuffed.html | work = New Scientist | access-date = 2010-07-21}}</ref> Unlike [[MON 810]], [[Bt 11]], and [[Bt 176]] which each produce a modified [[Cry1Ab]], MON 863 instead produces a modified Cry3Bb1 toxin and contains [[nptII]], a [[marker gene]] for [[antibiotic resistance]].<ref name='Greenpeace MON863 chronicle' /><ref name='Lorch 2005-09-30'>{{cite web | url = http://www.ifrik.org/files-ifrik/0509_greenpeace_mon863_hybrids.pdf | title = EFSA's Opinion on MON863 hybrids | access-date = 2010-07-22 | last = Lorch | first = Antje | date = 2005-09-30 | work = ifrik | publisher = [[Greenpeace]] | quote = MON863 contains an GM antibiotic resistance gene (nptII) against kanamycin and neomycin. | url-status = dead | archive-url = https://web.archive.org/web/20110726171634/http://www.ifrik.org/files-ifrik/0509_greenpeace_mon863_hybrids.pdf | archive-date = 2011-07-26 }}</ref>



==History==

==History==

In 2004, Monsanto sought approval in Europe to introduce MON 863. Approval was granted in 2005 for use in feed<ref>Staff (8 August 2005) [http://www.gmo-compass.org/pdf/regulation/maize/MON863_maize_decision_feed.pdf concerning the placing on the market, in accordance with Directive 2001/18/EC of the European Parliament and of the Council, of a maize product (Zea mays L., line MON 863) genetically modified for resistance to corn rootworm] Commission of the European Communities, Offical Journal, Retrieved 17 November 2012</ref> and in 2006 for use in food.<ref>Staff (13 January 2006) [http://www.gmo-compass.org/pdf/regulation/maize/MON863_maize_decision_food.pdf concerning the placing on the market, in accordance with Directive 2001/18/EC of the European Parliament and of the Council, of a maize product (Zea mays L., line MON 863) genetically modified for resistance to corn rootworm and in 2006 in food] Commission of the European Communities, Offical Journal, Retrieved 17 November 2012</ref> There was controversy over acceptance by regulatory bodies of industry-funded toxicity studies and over the design of those studies led by Pr [[Gilles-Éric Séralini]], who was on the committee that reviewed MON863 for the French government,<ref>[http://www.criigen.org/SiteEn/index.php?option=com_content&task=view&id=57&Itemid=105 Seralini bio on CRIIGEN]</ref>

In 2004, Monsanto sought approval in Europe to introduce MON 863. Approval was granted in 2005 for use in feed<ref>Staff (8 August 2005) [http://www.gmo-compass.org/pdf/regulation/maize/MON863_maize_decision_feed.pdf concerning the placing on the market, in accordance with Directive 2001/18/EC of the European Parliament and of the Council, of a maize product (Zea mays L., line MON 863) genetically modified for resistance to corn rootworm] {{Webarchive|url=https://web.archive.org/web/20101231200535/http://www.gmo-compass.org/pdf/regulation/maize/MON863_maize_decision_feed.pdf |date=2010-12-31 }} Commission of the European Communities, Official Journal, Retrieved 17 November 2012</ref> and in 2006 for use in food.<ref>Staff (13 January 2006) [http://www.gmo-compass.org/pdf/regulation/maize/MON863_maize_decision_food.pdf concerning the placing on the market, in accordance with Directive 2001/18/EC of the European Parliament and of the Council, of a maize product (Zea mays L., line MON 863) genetically modified for resistance to corn rootworm and in 2006 in food] {{Webarchive|url=https://web.archive.org/web/20120905152527/http://www.gmo-compass.org/pdf/regulation/maize/MON863_maize_decision_food.pdf |date=2012-09-05 }} Commission of the European Communities, Official Journal, Retrieved 17 November 2012</ref> There was controversy over acceptance by regulatory bodies of industry-funded toxicity studies and over the design of those studies led by Pr [[Gilles-Éric Séralini]], who was on the committee that reviewed MON863 for the French government.<ref>{{Cite web |url=http://www.criigen.org/SiteEn/index.php?option=com_content&task=view&id=57&Itemid=105 |title=Seralini bio on CRIIGEN |access-date=2012-09-22 |archive-url=https://web.archive.org/web/20140330131455/http://www.criigen.org/SiteEn/index.php?option=com_content&task=view&id=57&Itemid=105 |archive-date=2014-03-30 |url-status=dead }}</ref>



See [[genetically_modified_food_controversies#S.C3.A9ralini_criticisms_of_toxicity_study_designs_and_responses|Genetically modified food controversies]] for details of this controversy, which extended beyond MON 863.

See [[genetically_modified_food_controversies#S.C3.A9ralini_criticisms_of_toxicity_study_designs_and_responses|Genetically modified food controversies]] for details of this controversy, which extended beyond MON 863.



Following legal action by parties including the [[Swedish Board of Agriculture]] and [[Greenpeace]], a [[Münster]] appeals court ruled that Monsanto would be forced to publicly reveal its research data.<ref name='Reilly 2010-01-23'>{{cite news | first = Michael | last = Reilly | title = Is Genetically Modified Corn Toxic? | date = 2010-01-23 | url = http://news.discovery.com/earth/is-genetically-modified-corn-toxic.html | work = Discovery News | accessdate = 2010-07-21}}</ref>

Following legal action by parties including the [[Swedish Board of Agriculture]] and [[Greenpeace]], a [[Münster]] appeals court ruled that Monsanto would be forced to publicly reveal its research data.<ref name='Reilly 2010-01-23'>{{cite news | first = Michael | last = Reilly | title = Is Genetically Modified Corn Toxic? | date = 2010-01-23 | url = http://news.discovery.com/earth/is-genetically-modified-corn-toxic.html | work = Discovery News | access-date = 2010-07-21}}</ref>


==Modified mechanisms==

MON 863 is genetically altered to express a modified version of [[Cry3Bb1]], a delta endotoxin which originates from ''[[Bacillus thuringiensis]]''.<ref name='Greenpeace MON863 chronicle'>{{cite web | url = http://www.greenpeace.org/international/Global/international/planet-2/report/2007/3/mon863_chronicle_of_deception.pdf | title = The MON863 case - a chronicle of systematic deception | accessdate = 2010-07-22 | format = PDF | publisher = [[Greenpeace]] | quote = MON863 is a genetically modified corn that expresses a Bt-toxin. This toxin is a modified version of the delta endotoxin Cry3Bb1 which originates from the microorganism Bacillus thuringiensis. The genetic manipulation is aimed at protecting maize plants against a pest called corn rootworm (Diabrotica spp.). MON863 differs from other Bt-corns already placed on the market (MON810, BT11, Bt176), which produce a modified Cry1Ab toxin conferring resistance to a pest called European corn borer (Ostrinia nubilalis), in that it produces an artificial Cry3Bb1 toxin. In addition to the modified Cry3Bb1 toxin gene MON863 contains an antibiotic resistance marker gene.}}</ref><ref name='Doull 2007 genetics'>{{cite journal |doi=10.1016/j.fct.2007.08.033 |title=Report of an Expert Panel on the reanalysis by of a 90-day study conducted by Monsanto in support of the safety of a genetically modified corn variety (MON 863) |year=2007 |last1=Doull |first1=J. |last2=Gaylor |first2=D. |last3=Greim |first3=H.A. |last4=Lovell |first4=D.P. |last5=Lynch |first5=B. |last6=Munro |first6=I.C. |journal=[[Food and Chemical Toxicology]] |volume=45 |issue=11 |pages=2073–85 |pmid=17900781}}</ref> This protects the plant from [[Diabrotica|corn rootworm]].<ref name='Doull 2007 genetics' /><ref name='Coghlan 2010-01-22'>{{cite news | first = Andy | last = Coghlan | title = Engineered maize toxicity claims roundly rebuffed | date = 2010-01-22 | url = http://www.newscientist.com/article/mg20527444.000-engineered-maize-toxicity-claims-roundly-rebuffed.html | work = New Scientist | accessdate = 2010-07-21}}</ref> Unlike [[MON 810]], [[Bt 11]], and [[Bt 176]] which each produce a modified [[Cry1Ab]], MON 863 instead produces a modified Cry3Bb1 toxin and contains [[nptII]], a [[marker gene]] for [[antibiotic resistance]].<ref name='Greenpeace MON863 chronicle' /><ref name='Lorch 2005-09-30'>{{cite web | url = http://www.ifrik.org/files-ifrik/0509_greenpeace_mon863_hybrids.pdf | title = EFSA’s Opinion on MON863 hybrids | accessdate = 2010-07-22 | last = Lorch | first = Antje | date = 2005-09-30 | format = PDF | work = ifrik | publisher = [[Greenpeace]] | quote = MON863 contains an GM antibiotic resistance gene (nptII) against kanamycin and neomycin.}}</ref>



==Legal status==

==Legal status==

MON 863 is approved for use in [[Australia]], [[Canada]], [[China]], the [[European Union]], [[Japan]], [[Mexico]], [[New Zealand]], the [[Philippines]], [[Russia]], [[Singapore]], [[South Korea]], [[Taiwan]], and the [[United States]].<ref name='Monsanto safety sheet'>{{cite web | url = http://www.monsanto.com/products/techandsafety/safetysummaries/focus863.asp | title = Technical & Safety Information - Focus on MON 863 / YieldGard Rootworm | accessdate = 2010-07-22 | publisher = [[Monsanto]] | quote = Based on these reviews, this maize has been authorized for planting in the United States and Canada since 2003 and is additionally approved for import and food use in many countries around the world, including Japan, Korea, Taiwan, the Philippines, Australia/New Zealand, China, Russia, Singapore, Mexico and the European Union.}} {{Dead link|date=October 2010|bot=H3llBot}}</ref><ref>Staff [http://dmedia.ucsc.edu/~bsharris/film%20170a/proj3/monsanto/monsanto/layout/products/technicalandsafety/MON863.html Focus on MON 863 / YieldGard® Rootworm] Monsanto Consume, Technical And Safety Information, Accessed 5 April 2012</ref>

As of 2015, MON 863 is approved for cultivation in three countries: the United States, Japan, and Canada. The corn is approved for use in [[Australia]], [[Canada]], [[China]], the [[European Union]], [[Japan]], [[Mexico]], [[New Zealand]], [[Russia]], [[Singapore]], [[South Korea]], [[Taiwan]], and the [[United States]].<ref>Staff, ISAAA. Last updated July 27, 2015 [http://www.isaaa.org/gmapprovaldatabase/event/default.asp?EventID=87&Event=MON863 Event Name: MON863] See Authorizations tab. Accessed June 2, 2016</ref>



==See also==

==See also==

Line 18: Line 16:


==References==

==References==

{{reflist}}

{{reflist|2}}




{{corn}}{{Genetic engineering}}

{{Corn}}

{{Genetic engineering}}



{{DEFAULTSORT:Mon 863}}

{{DEFAULTSORT:Mon 863}}


Latest revision as of 01:46, 25 March 2023

MON 863 is a genetically engineered variety of maize produced by Monsanto. It is genetically altered to express a modified version of Cry3Bb1, a delta endotoxin which originates from Bacillus thuringiensis.[1][2] This protects the plant from corn rootworm.[2][3] Unlike MON 810, Bt 11, and Bt 176 which each produce a modified Cry1Ab, MON 863 instead produces a modified Cry3Bb1 toxin and contains nptII, a marker gene for antibiotic resistance.[1][4]

History[edit]

In 2004, Monsanto sought approval in Europe to introduce MON 863. Approval was granted in 2005 for use in feed[5] and in 2006 for use in food.[6] There was controversy over acceptance by regulatory bodies of industry-funded toxicity studies and over the design of those studies led by Pr Gilles-Éric Séralini, who was on the committee that reviewed MON863 for the French government.[7]

See Genetically modified food controversies for details of this controversy, which extended beyond MON 863.

Following legal action by parties including the Swedish Board of Agriculture and Greenpeace, a Münster appeals court ruled that Monsanto would be forced to publicly reveal its research data.[8]

Legal status[edit]

As of 2015, MON 863 is approved for cultivation in three countries: the United States, Japan, and Canada. The corn is approved for use in Australia, Canada, China, the European Union, Japan, Mexico, New Zealand, Russia, Singapore, South Korea, Taiwan, and the United States.[9]

See also[edit]

References[edit]

  1. ^ a b "The MON863 case - a chronicle of systematic deception" (PDF). Greenpeace. Retrieved 2010-07-22. MON863 is a genetically modified corn that expresses a Bt-toxin. This toxin is a modified version of the delta endotoxin Cry3Bb1 which originates from the microorganism Bacillus thuringiensis. The genetic manipulation is aimed at protecting maize plants against a pest called corn rootworm (Diabrotica spp.). MON863 differs from other Bt-corns already placed on the market (MON810, BT11, Bt176), which produce a modified Cry1Ab toxin conferring resistance to a pest called European corn borer (Ostrinia nubilalis), in that it produces an artificial Cry3Bb1 toxin. In addition to the modified Cry3Bb1 toxin gene MON863 contains an antibiotic resistance marker gene.
  • ^ a b Doull, J.; Gaylor, D.; Greim, H.A.; Lovell, D.P.; Lynch, B.; Munro, I.C. (2007). "Report of an Expert Panel on the reanalysis by of a 90-day study conducted by Monsanto in support of the safety of a genetically modified corn variety (MON 863)". Food and Chemical Toxicology. 45 (11): 2073–85. doi:10.1016/j.fct.2007.08.033. PMID 17900781.
  • ^ Coghlan, Andy (2010-01-22). "Engineered maize toxicity claims roundly rebuffed". New Scientist. Retrieved 2010-07-21.
  • ^ Lorch, Antje (2005-09-30). "EFSA's Opinion on MON863 hybrids" (PDF). ifrik. Greenpeace. Archived from the original (PDF) on 2011-07-26. Retrieved 2010-07-22. MON863 contains an GM antibiotic resistance gene (nptII) against kanamycin and neomycin.
  • ^ Staff (8 August 2005) concerning the placing on the market, in accordance with Directive 2001/18/EC of the European Parliament and of the Council, of a maize product (Zea mays L., line MON 863) genetically modified for resistance to corn rootworm Archived 2010-12-31 at the Wayback Machine Commission of the European Communities, Official Journal, Retrieved 17 November 2012
  • ^ Staff (13 January 2006) concerning the placing on the market, in accordance with Directive 2001/18/EC of the European Parliament and of the Council, of a maize product (Zea mays L., line MON 863) genetically modified for resistance to corn rootworm and in 2006 in food Archived 2012-09-05 at the Wayback Machine Commission of the European Communities, Official Journal, Retrieved 17 November 2012
  • ^ "Seralini bio on CRIIGEN". Archived from the original on 2014-03-30. Retrieved 2012-09-22.
  • ^ Reilly, Michael (2010-01-23). "Is Genetically Modified Corn Toxic?". Discovery News. Retrieved 2010-07-21.
  • ^ Staff, ISAAA. Last updated July 27, 2015 Event Name: MON863 See Authorizations tab. Accessed June 2, 2016


  • Retrieved from "https://en.wikipedia.org/w/index.php?title=MON_863&oldid=1146465889"

    Categories: 
    Genetically modified maize
    Monsanto
    Hidden categories: 
    Webarchive template wayback links
    Articles with short description
    Short description matches Wikidata
     



    This page was last edited on 25 March 2023, at 01:46 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki